The report on the Global Kidney/Renal Fibrosis Treatment Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Study period considered for research of global kidney/renal fibrosis treatment market:
- Base Year: 2015
- Estimated Year: 2016
- Forecast Till: 2022
A glimpse of the major drivers and restraints affecting the kidney/renal fibrosis treatment market is mentioned below:
Drivers
- Rising health awareness and health concerns
- Point-of-care drug delivery systems
- Rising incidences of chronic kidney disorder (CKDs) and renal fibrosis
Restraints
- Stringent regulatory approvals related with kidney fibrosis therapeutics
The report offers a value chain analysis that gives a comprehensive outlook of the kidney/renal fibrosis treatment market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.
The kidney/renal fibrosis treatment market has been segmented based on therapeutics such as angiotensin II receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, pirfenidone, renin inhibitors and vasopeptidase inhibitors. The study incorporates periodic market estimates and forecasts. Each therapeutics has been analyzed based on the market size at regional and country levels.
The kidney/renal fibrosis treatment market has been segmented based on diagnostic center such as hospital testing (commercial/private hospital, public health hospitals), clinics and home treatment. The report provides forecast and estimates for each diagnostic center in terms of market size during the study period. Each diagnostic center has been further analyzed based on regional and country levels.
Geographically, the kidney/renal fibrosis treatment market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The study details country-level aspects based on each segment and gives estimates in terms of market size.
The report also covers the complete competitive landscape of the global Kidney/Renal Fibrosis Treatment market with company profiles of key players such as:​
- BioLine Rx Ltd.
- F. Hoffman-La Roche Ltd.
- Galectin Therapeutics
- Genzyme Corporation
- InterMune Inc.
- La Jolla Pharmaceutical Company
- Merck & Co.
- Pfizer Inc.
- ProMetic Life-Sciences Inc.
A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments. This analysis gives a thorough idea about the competitive positioning of market players. The report also gives information of kidney/renal fibrosis treatment market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Kidney/Renal Fibrosis Treatment Market Analysis by Therapeutics:
- Angiotensin II Receptor Blockers (ARBs)
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Pirfenidone
- Renin Inhibitors
- Vasopeptidase Inhibitors
Kidney/Renal Fibrosis Treatment Market Analysis by Diagnostic Center:
- Hospital Testing
- Commercial/Private Hospitals
- Public Health Hospitals
- Clinics
- Home Treatment
Kidney/Renal Fibrosis Treatment Market Analysis by Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
The Global Kidney/Renal Fibrosis Treatment Market has been exhibited in detail in the following chapters -
Chapter 1 Kidney/Renal Fibrosis Treatment Market Preface
Chapter 2 Executive Summary
Chapter 3 Kidney/Renal Fibrosis Treatment Industry Analysis
Chapter 4 Kidney/Renal Fibrosis Treatment Market Value Chain Analysis
Chapter 5 Kidney/Renal Fibrosis Treatment Market Analysis By Therapeutics
Chapter 6 Kidney/Renal Fibrosis Treatment Market Analysis By Diagnostic Center
Chapter 7 Kidney/Renal Fibrosis Treatment Market Analysis By Geography
Chapter 8 Competitive Landscape Of Kidney/Renal Fibrosis Treatment Companies
Chapter 9 Company Profiles Of Kidney/Renal Fibrosis Treatment Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.